Lyra Therapeutics, Inc. (LYRA)
0.19
0.00 (0.00%)
USD |
OTCM |
Oct 14, 16:00
Lyra Therapeutics Max Drawdown (5Y) : 100.00% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 100.00% |
| August 31, 2026 | 100.00% |
| July 31, 2026 | 99.94% |
| June 30, 2026 | 99.94% |
| May 31, 2026 | 99.94% |
| April 30, 2026 | 99.94% |
| March 31, 2026 | 99.94% |
| February 28, 2026 | 99.87% |
| January 31, 2026 | 99.78% |
| December 31, 2025 | 99.63% |
| November 30, 2025 | 99.63% |
| October 31, 2025 | 99.54% |
| September 30, 2025 | 99.54% |
| August 31, 2025 | 99.54% |
| July 31, 2025 | 99.54% |
| June 30, 2025 | 99.54% |
| May 31, 2025 | 99.54% |
| April 30, 2025 | 99.54% |
| March 31, 2025 | 99.32% |
| February 28, 2025 | 99.10% |
| January 31, 2025 | 99.10% |
| December 31, 2024 | 99.10% |
| November 30, 2024 | 99.10% |
| October 31, 2024 | 98.82% |
| September 30, 2024 | 98.70% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.61% |
| July 31, 2024 | 98.61% |
| June 30, 2024 | 98.61% |
| May 31, 2024 | 98.25% |
| April 30, 2024 | 89.49% |
| March 31, 2024 | 89.49% |
| February 29, 2024 | 89.49% |
| January 31, 2024 | 89.49% |
| December 31, 2023 | 89.49% |
| November 30, 2023 | 89.49% |
| October 31, 2023 | 89.49% |
| September 30, 2023 | 89.49% |
| August 31, 2023 | 89.49% |
| July 31, 2023 | 89.49% |
| June 30, 2023 | 89.49% |
| May 31, 2023 | 89.49% |
| April 30, 2023 | 89.49% |
| March 31, 2023 | 89.49% |
| February 28, 2023 | 87.55% |
| January 31, 2023 | 86.85% |
| December 31, 2022 | 86.85% |
| November 30, 2022 | 81.63% |
| October 31, 2022 | 81.14% |
| September 30, 2022 | 81.14% |
| August 31, 2022 | 81.14% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Filana Therapeutics, Inc. | 99.34% |
| CorMedix, Inc. | 84.47% |
| Eloxx Pharmaceuticals, Inc. | 100.0% |
| Breakthrough Chemistry, Inc. | 99.04% |
| BioStem Technologies, Inc. | 94.21% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -94.20 |
| Beta (5Y) | 0.4982 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 400.1% |
| Historical Sharpe Ratio (5Y) | -0.223 |
| Historical Sortino (5Y) | -1.273 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 53.66% |